AEGIR — Aegirbio AB Income Statement
0.000.00%
- SEK14.76m
- SEK51.57m
- SEK0.09m
Annual income statement for Aegirbio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 11 W | 10 W | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.014 | 13.3 | 1.71 | 0.092 |
Cost of Revenue | |||||
Gross Profit | — | — | 5.51 | -23.7 | 0.044 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | — | 18.5 | 95.8 | 367 | 56.3 |
Operating Profit | 0 | -18.5 | -82.6 | -365 | -56.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0 | -18.5 | -92.7 | -364 | -61.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0 | -18.5 | -92.3 | -363 | -59.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -0 | -18.5 | -92.3 | -363 | -59.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0 | -18.5 | -92.3 | -363 | -59.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -1.42 | -5.54 | -9.53 | -2.38 |
Dividends per Share |